Pierre-francois Meyer

Kirkland, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.

Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.

Journal: Clinical colorectal cancer

Published: September 01, 2023

Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.

Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 26, 2022

Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.

Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.

Journal: JAMA neurology

Published: August 22, 2022

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum.

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum.

Journal: Genes

Published: October 13, 2021

Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.

Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.

Journal: Annals of neurology

Published: May 02, 2021

Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: January 13, 2021

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 10, 2021

Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes.

Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes.

Journal: NeuroImage

Published: October 30, 2020

Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.

Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.

Journal: Neurology

Published: April 02, 2020

Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use.

Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use.

Journal: JAMA network open

Published: February 08, 2020

Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.

Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.

Journal: JAMA neurology

Published: January 22, 2020

AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.

AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.

Journal: Progress in molecular biology and translational science

Published: September 05, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026